SU014813

DRUG2 trials

Sponsors

Pfizer

Conditions

Breast NeoplasmsNeoplasmsSolid Tumors

Phase 1

A Trial Of SU14813 In Patients With Advanced Solid Malignancies

CompletedNCT00982267

PfizerNeoplasms, Solid Tumors

Start: 2003-12-31End: 2011-06-30Updated: 2011-08-08

Phase 2

Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

CompletedNCT00322517

PfizerBreast Neoplasms

Start: 2006-04-30End: 2009-07-31Updated: 2011-05-17